Comparison of DNA‐adduct and tissue‐available dose levels of MeIQx in human and rodent colon following administration of a very low dose

[2‐14C]2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline (MeIQx) was administered orally (304 ng/kg body‐weight dose based upon an average 70‐kg‐body‐weight subject) to 5 human colon‐cancer patients (58 to 84 years old), as well as to F344 rats and B6C3F1 mice. Colon tissue was collected from the human subjects at surgery and from the rodents 3.5 to 6 hr after administration. Colon DNA‐adduct levels and tissue available doses were measured by accelerator mass spectrometry (AMS). The mean levels of MeIQx in the histologically normal colon tissue were not different among the human (97 ± 26 pg MeIQx/g), rat (133 ± 15 pg/g) or mouse (78 ± 10 pg/g) tissues; and no difference existed between the levels detected in human normal and tumor tissue (101 ± 15 pg/g). Mean DNA‐adduct levels in normal human colon (26 ± 4 adducts/1012 nucleotides) were significantly greater (p < 0.01) than in rats (17.1 ± 1 adduct/1012 nucleotides) or mice (20.6 ± 0.9 adduct/1012 nucleotides). No difference existed in adduct levels between normal and tumor tissue in humans. These results show that MeIQx forms DNA adducts in human colon at low dose, and that the human colon may be more sensitive to the effects of MeIQx than that of mice or rats. Int. J. Cancer 80:539–545, 1999. © 1999 Wiley‐Liss, Inc.

[1]  T. Sugimura,et al.  Identification of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethyl-imidazo[4,5- f]quinoxaline 3',5'-diphosphate, a major DNA adduct, detected by nuclease P1 modification of the 32P-postlabeling method, in the liver of rats fed MeIQx. , 1993, Carcinogenesis.

[2]  H. Ohgaki,et al.  Carcinogenicities of heterocyclic amines in cooked food. , 1991, Mutation research.

[3]  K. Turteltaub,et al.  Accelerator mass spectrometry. , 1995, Analytical chemistry.

[4]  K T Bogen,et al.  Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. , 1995, Carcinogenesis.

[5]  K. Turteltaub,et al.  Dose-response studies of MeIQx in rat liver and liver DNA at low doses. , 1995, Carcinogenesis.

[6]  J. Lay,et al.  Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. , 1992, Chemical research in toxicology.

[7]  K. Turteltaub,et al.  Accelerator mass spectrometry : isotope quantification at attomole sensitivity , 1995 .

[8]  R C Garner,et al.  A preliminary evaluation of accelerator mass spectrometry in the biomedical field. , 1997, Journal of pharmaceutical and biomedical analysis.

[9]  S R Tannenbaum,et al.  Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx). , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  K. Turteltaub,et al.  The metabolic disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the induced mouse. , 1989, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  S. Tannenbaum,et al.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring. , 1994, Environmental health perspectives.

[12]  A. Boobis,et al.  N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver. , 1992, Carcinogenesis.

[13]  T. Sugimura,et al.  Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues. , 1996, Carcinogenesis.

[14]  M A Butler,et al.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  M. Butler,et al.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. , 1991, Carcinogenesis.

[16]  W. Lutz,et al.  In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. , 1979, Mutation research.

[17]  S. Leveson,et al.  Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans. , 1998, Chemical research in toxicology.

[18]  J. Mordenti,et al.  Expression of Exposure in Negative Carcinogenicity Studies: Dose/Body Weight, Dose/Body Surface Area, or Plasma Concentrations? , 1995, Toxicologic pathology.

[19]  K. Turteltaub,et al.  MeIQx-DNA adduct formation in rodent and human tissues at low doses. , 1997, Mutation research.

[20]  P. Kuzmicky,et al.  Airborne mutagens produced by frying beef, pork and a soy-based food. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  R. Edwards,et al.  Enzymatic studies of the activation of heterocyclic food mutagens in man. , 1995, Princess Takamatsu symposia.

[22]  J. Southon,et al.  Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.